Skip to content
MedsAcross

Medicine

Clopidogrel 300 mg tablet

Clopidogrel · Oral
Available on requestPrescription onlyUS FDAGeneric name

Clopidogrel 300 mg tablet is a generic prescription medicine for oral use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25° C (77° F), excursions permitted to 15° to 30° C (59° to 86° F).

Key facts

Active ingredient (INN)
Clopidogrel
Brand
Sold under the generic name
Strength
300 mg
Dosage form
Tablet
Route
Oral
Packs
500 tablets, 30 tablets, 5 blister pack and 37 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaCamber PharmaceuticalsIndiaProficient RxVensun PharmaceuticalsRadha PharmaceuticalsScieGen PharmaceuticalsAmerican Health PackagingMajor PharmaceuticalsWestminster PharmaceuticalsApotex
Origin register
US FDA, United States
Storage
Store at 25° C (77° F), excursions permitted to 15° to 30° C (59° to 86° F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
B01AC03 Clopidogrel
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
17 May 2012
Identifiers
RxCUI 309362, 749196DailyMed set ID 16aef4f6-6b90-4d5f-9e07-c9927adf3841, 330702d9-842c-416d-9b11-b4a9b707e9b2, 4cd07a3c-9673-4aa0-b76a-d79df2399ee1 +10NDC 77771-121, 82804-986, 0904-6467 +10Application ANDA204165, ANDA076274, ANDA091023 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
500 tablet, film coated in 1 bottle43598-122-05Dr. Reddy's LaboratoriesIndia15 April 2025
30 tablet, film coated in 1 bottle43598-122-30Dr. Reddy's LaboratoriesIndia15 April 2025
5 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack43598-122-59Dr. Reddy's LaboratoriesIndia15 April 2025
100 tablet, film coated in 1 bottle55111-671-01Dr. Reddy's LaboratoriesIndia17 May 2012
500 tablet, film coated in 1 bottle55111-671-05Dr. Reddy's LaboratoriesIndia17 May 2012
30 tablet, film coated in 1 bottle55111-671-30Dr. Reddy's LaboratoriesIndia17 May 2012
5 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack55111-671-31Dr. Reddy's LaboratoriesIndia17 May 2012
1 blister pack in 1 carton / 4 tablet, film coated in 1 blister pack55111-671-48Dr. Reddy's LaboratoriesIndia17 May 2012
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack55111-671-78Dr. Reddy's LaboratoriesIndia17 May 2012
3 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack55111-671-81Dr. Reddy's LaboratoriesIndia17 May 2012
90 tablet, film coated in 1 bottle55111-671-90Dr. Reddy's LaboratoriesIndia17 May 2012
500 tablet in 1 bottle31722-759-05Camber PharmaceuticalsIndia4 August 2023
30 tablet in 1 bottle31722-759-30Camber PharmaceuticalsIndia4 August 2023
500 tablet, film coated in 1 bottle60505-3532-5Apotex4 March 2014
500 tablet, film coated in 1 bottle77771-121-05Radha Pharmaceuticals20 February 2023
30 tablet, film coated in 1 bottle77771-121-30Radha Pharmaceuticals20 February 2023
90 tablet, film coated in 1 bottle77771-121-90Radha Pharmaceuticals20 February 2023
500 tablet, film coated in 1 bottle50228-121-05ScieGen Pharmaceuticals15 September 2015
30 tablet, film coated in 1 bottle50228-121-30ScieGen Pharmaceuticals15 September 2015
90 tablet, film coated in 1 bottle50228-121-90ScieGen Pharmaceuticals15 September 2015
100 tablet in 1 bottle42543-714-01Vensun Pharmaceuticals1 November 2014
500 tablet in 1 bottle42543-714-05Vensun Pharmaceuticals1 November 2014
30 tablet in 1 bottle42543-714-30Vensun Pharmaceuticals1 November 2014
90 tablet in 1 bottle42543-714-90Vensun Pharmaceuticals1 November 2014
20 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack68084-752-19American Health Packaging12 July 2023
30 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack68084-752-25American Health Packaging31 March 2014
20 blister pack in 1 box / 1 tablet, film coated in 1 blister pack50268-184-12AvPAK11 October 2019
30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack0904-6467-07Major Pharmaceuticals6 April 2015
20 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack0904-6467-10Major Pharmaceuticals6 April 2015
100 tablet, film coated in 1 bottle, plastic82804-986-00Proficient Rx21 May 2024
30 tablet, film coated in 1 bottle, plastic82804-986-30Proficient Rx21 May 2024
500 tablet, film coated in 1 bottle, plastic82804-986-55Proficient Rx21 May 2024
60 tablet, film coated in 1 bottle, plastic82804-986-60Proficient Rx21 May 2024
240 tablet, film coated in 1 bottle, plastic82804-986-64Proficient Rx21 May 2024
120 tablet, film coated in 1 bottle, plastic82804-986-72Proficient Rx21 May 2024
180 tablet, film coated in 1 bottle, plastic82804-986-78Proficient Rx21 May 2024
90 tablet, film coated in 1 bottle, plastic82804-986-90Proficient Rx21 May 2024
5 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack63739-178-30SKY Packaging18 August 2022
500 tablet, film coated in 1 bottle, plastic69367-194-05Westminster Pharmaceuticals27 July 2018
30 tablet, film coated in 1 bottle, plastic69367-194-30Westminster Pharmaceuticals27 July 2018

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 17 November 1997Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Clopidogrel 300 mg tablet.

Compare 1

Other strengths and forms of Clopidogrel

Clinical summary

Clopidogrel is a P2Y12 platelet inhibitor indicated for acute coronary syndrome – For patients with non–ST-segment elevation ACS (unstable angina [UA]/non–ST-elevation myocardial infarction [NSTEMI]), among other approved uses. MedsAcross supplies Clopidogrel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Clopidogrel

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Clopidogrel 300 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.